MeSH tree: C04.588.894.797.520.109.220.249
A subset of patients with non-small cell lung cancer (NSCLC) who discontinued immune checkpoint inhibitor (ICI) therapy due to immune-related adverse events (irAEs) continued to experience long-term disease control, according ...
Apr 21, 2025
0
20
A new study published in The Annals of Thoracic Surgery suggests that Medicaid expansion under the Affordable Care Act has significantly improved access to timely treatment and high-volume hospitals for patients with early-stage ...
Apr 15, 2025
0
14
In localized non-small cell lung cancer (NSCLC), a tumor's ability to use carbon from glucose to feed the tricarboxylic acid (TCA) cycle predicts cancer spread beyond the lung, months to years before metastases are clinically ...
Feb 19, 2025
0
11
An investigational therapy significantly shrank lung cancer tumors that are notoriously resistant to treatment by encouraging an attack from natural killer (NK) cells in an animal model, a study led by UT Southwestern Medical ...
Feb 17, 2025
0
61
A study published in Science Advances reveals a novel strategy that allows tumors to evade the body's immune response critical for their elimination. Researchers at Baylor College of Medicine and collaborating institutions ...
Feb 12, 2025
0
12
A new study led by researchers from Moffitt Cancer Center, in collaboration with investigators from the University of Michigan, shows that artificial intelligence (AI) can help doctors make better decisions when treating ...
Jan 30, 2025
0
61
There are two main types of lung cancer: small cell and non-small cell. According to the American Cancer Society, non-small cell lung cancer is often categorized in one of two stages: limited or extensive.
Jan 22, 2025
0
24
A new study examining the use of high-cost drugs among patients with colorectal cancer and non-small cell lung cancer found those insured through Medicare Advantage received less expensive cancer drugs compared to others ...
Jan 10, 2025
0
47
Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that could help medical professionals better target and treat cancer.
Dec 17, 2024
0
31
The first computer algorithm capable of identifying which tumor cells are driving aggressive cancer growth has been developed by scientists from UCL and The Francis Crick Institute.
Dec 3, 2024
0
22
